elidel 10 mg/g creme
nordic prime aps - pimecrolimus - creme - 10 mg/g
tysabri
biogen netherlands b.v. - natalizumab - multipel sclerose - selektive immunosuppressiva - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 og 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.
candesartancilexetil "actavis" 16 mg tabletter
actavis group ptc ehf. - candesartancilexetil - tabletter - 16 mg
candesartancilexetil "actavis" 32 mg tabletter
actavis group ptc ehf. - candesartancilexetil - tabletter - 32 mg
candesartancilexetil "actavis" 8 mg tabletter
actavis group ptc ehf. - candesartancilexetil - tabletter - 8 mg
candesartan "orion" 16 mg tabletter
orion corporation - candesartancilexetil - tabletter - 16 mg
candesartan "orion" 32 mg tabletter
orion corporation - candesartancilexetil - tabletter - 32 mg
candesartan "orion" 8 mg tabletter
orion corporation - candesartancilexetil - tabletter - 8 mg
citalopram "orifarm" 20 mg filmovertrukne tabletter
orifarm generics a/s - citalopramhydrobromid - filmovertrukne tabletter - 20 mg
citalopram "orifarm" 30 mg filmovertrukne tabletter
orifarm generics a/s - citalopramhydrobromid - filmovertrukne tabletter - 30 mg